Cite
MLA Citation
S Vermeire et al.. “P379 Effect of upadacitinib on inflammatory markers and clinical outcomes in patients with Crohn's disease in the phase 3, U-EXCEL, U-EXCEED, and U-ENDURE studies.” Journal of Crohn's and colitis, vol. 17, n.d., pp. i510–i513. http://access.bl.uk/ark:/81055/vdc_100179842300.0x00001c